Get the Stockscreener App
1.91
1.06%
0.02
After Hours:
1.90
-0.01
-0.52%
Citius Oncology Inc stock is traded at $1.91, with a volume of 111.28K.
It is up +1.06% in the last 24 hours and up +13.02% over the past month.
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
See More
Previous Close:
$1.89
Open:
$1.88
24h Volume:
111.28K
Relative Volume:
0.08
Market Cap:
$149.69M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.60%
1M Performance:
+13.02%
6M Performance:
+142.08%
1Y Performance:
+16.46%
1-Day Range:
$1.83
$1.96
1-Week Range:
$1.7238
$2.09
52-Week Range:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Name
Citius Oncology Inc
Sector
Phone
(908) 967-6677
Address
11 COMMERCE DRIVE, CRANFORD
Compare CTOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
1.91 | 146.55M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-27-24 | Initiated | Maxim Group | Buy |
Citius Oncology Inc Stock (CTOR) Latest News
Strategies to average down on Citius Oncology Inc.Market Trend Summary & Daily Technical Forecast Reports - Newser
Can machine learning forecast Citius Oncology Inc. recoveryWeekly Investment Summary & AI Powered Trade Plan Recommendations - Newser
How institutional ownership impacts Citius Oncology Inc. stockJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Price action breakdown for Citius Oncology Inc.Watch List & Real-Time Volume Trigger Notifications - Newser
Citius Oncology (NASDAQ:CTOR) Shares Up 3.3%Still a Buy? - MarketBeat
Visualizing Citius Oncology Inc. stock with heatmapsEarnings Recap Report & Capital Efficient Trade Techniques - Newser
Can a trend reversal in Citius Oncology Inc. lead to recoveryJuly 2025 Decliners & Community Consensus Picks - Newser
What momentum shifts mean for Citius Oncology Inc.Analyst Upgrade & Capital Efficient Trading Techniques - Newser
Citius Oncology Raises $7.48M in Direct Offering - TipRanks
Citius Oncology closes $9 million offering to fund cancer therapy - Investing.com
Citius Oncology closes $9 million offering to fund cancer therapy By Investing.com - Investing.com Nigeria
Citius Oncology announces closing of $9 million registered direct offering and concurrent private placement - MarketScreener
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - PR Newswire
What indicators show strength in Citius Oncology Inc.July 2025 Closing Moves & Verified Momentum Stock Ideas - Newser
Citius Oncology raises $9 million in stock offering By Investing.com - Investing.com Australia
Can swing trading help recover from Citius Oncology Inc. lossesJuly 2025 Trends & Safe Capital Growth Plans - Newser
Can trapped investors hope for a rebound in Citius Oncology Inc.Trade Analysis Report & Weekly Momentum Picks - Newser
Citius Oncology Raises $9 Mln Through Direct Offering And Private Placement - Nasdaq
Citius Oncology raises $9 million in stock offering - Investing.com
Citius Oncology prices $9M direct offering & private placement - MarketScreener
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - PR Newswire
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - Benzinga
Chart based analysis of Citius Oncology Inc. trendsPortfolio Value Report & Accurate Buy Signal Notifications - Newser
Will Citius Oncology Inc. rebound enough to break evenWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Developing predictive dashboards with Citius Oncology Inc. dataQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
How moving averages guide Citius Oncology Inc. tradingTrade Risk Assessment & Low Risk High Reward Ideas - Newser
Why is Citius Oncology Inc. stock going downJuly 2025 Pullbacks & Advanced Technical Signal Analysis - beatles.ru
Using R and stats models for Citius Oncology Inc. forecastingQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Intrinsic Value of Citius Oncology Inc. Stock: Is It Undervalued or OvervaluedSwing Trade & Technical Pattern Based Buy Signals - Newser
Is Citius Oncology Inc. still worth holding after the dipWeekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Smart tools for monitoring Citius Oncology Inc.’s price actionJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
What MACD signals say about Citius Oncology Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
Can Citius Oncology, Inc. deliver alphaMarket Risk Summary & High Conviction Buy Zone Picks - 시사인 투데이
Is Citius Oncology Inc. showing insider buyingJuly 2025 Movers & Long Hold Capital Preservation Tips - خودرو بانک
Is Citius Oncology Inc. stock a value trapDay Trade & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Can Citius Oncology Inc. maintain its current growth rate2025 Key Lessons & Real-Time Buy Signal Notifications - خودرو بانک
How do insiders feel about Citius Oncology Inc.Trade Exit Summary & Verified Momentum Watchlists - خودرو بانک
Citius Oncology Inc. stock chart pattern explainedJuly 2025 Trends & AI Powered Trade Plan Recommendations - Newser
What machine learning models say about Citius Oncology Inc.Quarterly Portfolio Report & Expert Curated Trade Setups - Newser
Can technical indicators confirm Citius Oncology Inc.’s reversalQuarterly Market Summary & Verified Swing Trading Watchlist - Newser
Automated trading signals detected on Citius Oncology Inc.July 2025 PostEarnings & Technical Pattern Alert System - Newser
Citius Oncology Inc. stock trend outlook and recovery pathQuarterly Profit Review & Technical Pattern Recognition Alerts - Newser
Chart based exit strategy for Citius Oncology Inc.2025 Major Catalysts & Target Return Focused Picks - Newser
Does Citius Oncology Inc. stock reflect fundamentalsPortfolio Update Summary & Low Drawdown Investment Strategies - خودرو بانک
P 500CEO Change & AI Driven Stock Price Forecasts - خودرو بانک
Is this a good reentry point in Citius Oncology Inc.Weekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
Analyzing Citius Oncology Inc. with multi timeframe chartsAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Citius Oncology Inc Stock (CTOR) Financials Data
There is no financial data for Citius Oncology Inc (CTOR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):